Allison Carles

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Blood Brain Barrier

Molecular Dynamics

Top Venues

International journal of molecular sciences

CNS neuroscience & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Allison Carles, Matthias Hoffmann, Matthias Scheiner, Lucie Crouzier, Christelle Bertrand-Gaday, Arnaud Chatonnet, Michael Decker, Tangui Maurice
The selective butyrylcholinesterase inhibitor UW-MD-95 shows symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer's disease. CNS neuroscience & therapeutics 30 (6) (2024)
Allison Carles, Aline Freyssin, Florent Perin-Dureau, Gilles Rubinstenn, Tangui Maurice
Targeting N -Methyl-d-Aspartate Receptors in Neurodegenerative Diseases. International journal of molecular sciences 25 (7) (2024)
Allison Carles, Aline Freyssin, Florent Perin-Dureau, Gilles Rubinstenn, Tangui Maurice
Targeting N -Methyl-d-Aspartate Receptors in Neurodegenerative Diseases. International journal of molecular sciences 25 (7) (2024)
Allison Carles, Aline Freyssin, Florent Perin-Dureau, Gilles Rubinstenn, Tangui Maurice
Targeting N -Methyl-d-Aspartate Receptors in Neurodegenerative Diseases. International journal of molecular sciences 25 (7) (2024)
Allison Carles, Matthias Hoffmann, Matthias Scheiner, Lucie Crouzier, Christelle Bertrand-Gaday, Arnaud Chatonnet, Michael Decker, Tangui Maurice
The selective butyrylcholinesterase inhibitor UW-MD-95 shows symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer's disease. CNS neuroscience & therapeutics 30 (6) (2024)